Pelthos Therapeutics
Price & Volume
Stats
See more52W Range | $16.50-$37.50 |
Market Cap | $91.2M |
Shares Short | 70,670 |
Financials
See moreRevenue (12 Mos) | $27.7M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $20.8M |
Diluted EPS | -$22.92 |
News
See moreYahoo Finance • last month
Pelthos Therapeutics Added to Russell 3000E™ Growth Benchmark, Russell Microcap® and Russell Microcap® Growth Benchmark Indexes
Yahoo Finance • 3 months ago
Pelthos Therapeutics to Report First Quarter 2026 Financial Results on May 14, 2026
Yahoo Finance • 4 months ago
Pelthos Therapeutics Announces CFO Transition
Yahoo Finance • 5 months ago
Quant snapshot: Micron, Babcock & Wilcox lead strong buys as Fold Holdings, Alvotech lag
About
CEO | Mr. Scott M. Plesha |
CFO | Mr. John M. Gay CPA |
Address | 4020 Stirrup Creek Drive, Durham, NC, United States, 27703 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 92 |